The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.
Total H Index | AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total |
1 | 217 | 6,024 | 17,820 |
![]() |
![]() |
Others
|
82 | 41 | 0.500 | |
3 | 341 | 8,975 | 26,235 |
![]() |
![]() |
Others
Drug metabolism and disposition | |
73 | 38 | 0.521 | |
7 | 601 | 15,385 | 44,455 |
![]() |
![]() |
Others
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients | |
61 | 48 | 0.787 | |
8 | 628 | 16,136 | 46,581 |
![]() |
![]() |
Others
Clinical Trials | Longitudinal Data | Evidence Synthesis | |
60 | 49 | 0.817 | |
15 | 974 | 24,086 | 68,271 |
![]() |
![]() |
Others
drug discovery and development | viruses and epithelial biology | non coding RNA | post translational modification | |
53 | 25 | 0.472 | |
16 | 1,004 | 24,767 | 70,320 |
![]() |
![]() |
Others
|
52 | 35 | 0.673 | |
18 | 1,050 | 25,892 | 73,434 |
![]() |
![]() |
Others
meta-analysis | missing data | statistics | biostatistics | miscellaneous statistical theory | |
51 | 38 | 0.745 | |
20 | 1,215 | 29,906 | 84,041 |
![]() |
![]() |
Others
Cancer | |
49 | 23 | 0.469 | |
22 | 1,302 | 31,645 | 88,653 |
![]() |
![]() |
Others
Cardiovascular | Drug Discovery & Development | |
48 | 21 | 0.438 | |
23 | 1,320 | 32,031 | 89,919 |
![]() |
![]() |
Others
Lymphocyte Biology | Lymphomagenesis | Therapeutics | |
47 | 38 | 0.809 | |
![]() |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
![]() |
||||||||
29 | 1,491 | 36,648 | 102,261 |
![]() |
![]() |
Others
|
45 | 28 | 0.622 | |
30 | 1,601 | 39,090 | 108,945 |
![]() |
![]() |
Others
|
44 | 23 | 0.523 | |
32 | 1,935 | 46,852 | 130,037 |
![]() |
![]() |
Others
Sustainability | Environmental Risk Assessment | Persistence Assessment | Antimicrobial Resistance | Biodegradability | |
40 | 35 | 0.875 | |
33 | 1,957 | 47,385 | 131,519 |
![]() |
![]() |
Others
|
40 | 31 | 0.775 | |
38 | 2,067 | 50,093 | 138,921 |
![]() |
![]() |
Others
|
39 | 31 | 0.795 | |
45 | 2,190 | 52,851 | 146,521 |
![]() |
![]() |
Others
MS imaging | molecular imaging | |
38 | 31 | 0.816 | |
47 | 2,305 | 55,308 | 152,782 |
![]() |
![]() |
Others
arrhythmias | heart failure | |
38 | 14 | 0.368 | |
49 | 2,328 | 55,900 | 154,748 |
![]() |
![]() |
Others
Diabetes | Cardiovascular disease | Heart failure | Kidney disease | Hypertension | |
37 | 31 | 0.838 | |
52 | 2,465 | 59,295 | 163,841 |
![]() |
![]() |
Others
Lipoproteins | Coronary artery disease | Heart failure | Inflammation | Cardiovascular disease | |
36 | 30 | 0.833 | |
54 | 2,530 | 61,016 | 168,275 |
![]() |
![]() |
Others
Drug discovery and development | Nucleotide therapeutics | Targeted drug delivery | chirality | drug metabolism | |
36 | 23 | 0.639 | |
56 | 2,553 | 61,937 | 170,474 |
![]() |
![]() |
Others
drug discovery | kinase | cell biology | Alzheimer's disease | |
36 | 18 | 0.500 | |
57 | 2,632 | 63,600 | 175,569 |
![]() |
![]() |
Others
Early Phase Oncology | |
35 | 26 | 0.743 | |
61 | 2,879 | 69,105 | 190,141 |
![]() |
![]() |
Others
Diabetes | |
34 | 20 | 0.588 | |
62 | 2,902 | 69,648 | 191,417 |
![]() |
![]() |
Others
|
34 | 17 | 0.500 | |
63 | 2,933 | 70,342 | 193,772 |
![]() |
![]() |
Others
|
33 | 30 | 0.909 |